Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renate Pichler

Showing results (61-70 of 196) with videos related to

Pageof 20
Sort By:
Plos One|February 7, 2015
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceIsabel Heidegger, Viktor Skradski, Eberhard Steiner, et al.
Clinical & Experimental Metastasis|August 8, 2025
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinomaNadja Kührer, Irene Huebner-Resch, Roman Mayr, et al.
Urologia Internationalis|June 6, 2013
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraineRenate Pichler, Isabel Heidegger, Gerald Klinglmair, et al.
The Prostate|August 27, 2015
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?Isabel Heidegger, Julia Höfer, Markus Luger, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2016
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancerRenate Pichler, Georg Gruenbacher, Zoran Culig, et al.
Cancer Communications (London, England)|August 20, 2024
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapiesMaxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Current Opinion in Urology|March 13, 2026
Latest developments in urinary tumor DNA and its current clinical role in urothelial bladder cancer and upper tract urothelial carcinomaDaniel A González-Padilla, José Daniel Subiela, Félix Guerrero-Ramos, et al.
BJU International|October 31, 2012
Influence of achieved paternity on quality of life in testicular cancer survivorsBrigitte Stoehr, Lydia Schachtner, Renate Pichler, et al.
Radiology|June 20, 2017
Value of Multiparametric US in the Assessment of Intratesticular LesionsThomas Auer, Tobias De Zordo, Christian Dejaco, et al.
Clinical Genitourinary Cancer|July 2, 2018
Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk PatientsRenate Pichler, Josef Fritz, Felizian Lackner, et al.
Pageof 20

Showing results (61-70 of 196) with videos related to

Sort By:
Pageof 20
Plos One|February 7, 2015
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceIsabel Heidegger, Viktor Skradski, Eberhard Steiner, et al.
Clinical & Experimental Metastasis|August 8, 2025
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinomaNadja Kührer, Irene Huebner-Resch, Roman Mayr, et al.
Urologia Internationalis|June 6, 2013
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraineRenate Pichler, Isabel Heidegger, Gerald Klinglmair, et al.
The Prostate|August 27, 2015
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?Isabel Heidegger, Julia Höfer, Markus Luger, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2016
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancerRenate Pichler, Georg Gruenbacher, Zoran Culig, et al.
Cancer Communications (London, England)|August 20, 2024
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapiesMaxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Current Opinion in Urology|March 13, 2026
Latest developments in urinary tumor DNA and its current clinical role in urothelial bladder cancer and upper tract urothelial carcinomaDaniel A González-Padilla, José Daniel Subiela, Félix Guerrero-Ramos, et al.
BJU International|October 31, 2012
Influence of achieved paternity on quality of life in testicular cancer survivorsBrigitte Stoehr, Lydia Schachtner, Renate Pichler, et al.
Radiology|June 20, 2017
Value of Multiparametric US in the Assessment of Intratesticular LesionsThomas Auer, Tobias De Zordo, Christian Dejaco, et al.
Clinical Genitourinary Cancer|July 2, 2018
Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk PatientsRenate Pichler, Josef Fritz, Felizian Lackner, et al.
Pageof 20